Latin America Pharma and Healthcare Sector Report 2025-2026

Latin America is a key pharmaceutical and healthcare market. The region's growing economies, coupled with an ageing population and increased life expectancy across the board, translate to an ever-growing demand for medicine and health-related services. Despite its attractiveness as a market, Latin America remains reliant on imported pharmaceutical goods due to its limited manufacturing capacity in most countries. In addition, production in most countries remains largely focused on low complexity goods, with deficient participation in advanced medical supply chains. Significant capital investments will be needed for the region to exploit its potential.

This report provides a complete and detailed analysis of the "Pharmaceuticals production" sector for South America. EMIS Insights presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

What this report allows you to do:

• Understand the key elements at play in the "Pharmaceuticals production" sector in South America
• Crystallise the forces both driving and restraining this sector in South America
• Ascertain South America’s position in the global sector
• Build a complete perspective on sector trade, investment and employment
• Understand the competitive landscape and who the major players are
• View M&A activity and major deals
• Gain an understanding of the regulatory environment for the sector in South America.
• Build a clear picture of trends, output and consumption for specific sub-sectors